节点文献

沙丁胺醇与特布他林治疗支气管哮喘和慢性阻塞性肺病的疗效比较

A Comparative Analysis on the Effect of Two Agonists in Asthma and COPD

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 沈继奋李承红李西方叶舟夏筱娟王传海蔡冬兰

【Author】 Shen Jifen, Li Chenghong, Li Xifang, et alDepartment of Internal Medicine, Affiliated Hospital of Wuhan Worker’s Medical College, Wuhan 430015

【机构】 武汉市职工医学院附院内科武汉市职工医学院肺功能室 430015

【摘要】 用沙丁胺醇控释剂与特布他林进行对比,共治疗支气管哮喘和慢性阻塞性肺病患者38例。结果显示两组总有效率相似(P>0.05)。用沙丁胺醇或特布他林后30分,10d后与用药前比较,FEV1.0和PEF均有显著改善(P<0.01),但用药后8h,特布他林对FEV1.0和PEF的作用减退,沙丁胺醇仍有疗效(P<0.01)。我们认为两种药物均有显著效果,但对夜间发作的支气管哮喘,应用沙丁胺醇需增加用药的次数,控释剂型有其优越性。

【Abstract】 8 cases of asthma and COPD were treated with release-controlled salbutamol (VOLMAX) or Bricahyl. The total effective rate were similar (P<0. 05). FEV1 and PEF were significantly improved (P<0. 01) 30 min and 10 days after treatment. However, the effect of Bricanyl abated 8h after administration, while the effect of Salbutamol remained (P<0.01). It is suggested that the above-mentioned B2-agonists are both effective in the treatment of asthma and COPD. When Bricanyl is used for treating asthma during night, it should be administered more frequently or a release-controlled preparation should be used.

【关键词】 沙丁胺醇特布他林支气管哮喘慢性阻塞性肺病
【Key words】 VOLMAXBricanylasthmaCOPD
  • 【文献出处】 药物流行病学杂志 ,Chinese Journal of Pharmaco Epidemiology , 编辑部邮箱 ,1996年01期
  • 【分类号】R562.25;
  • 【被引频次】4
  • 【下载频次】256
节点文献中: 

本文链接的文献网络图示:

本文的引文网络